Global, 3-dimensional approach to natural rejuvenation: Part 1 - recommendations for volume restoration and the periocular area

Journal of Cosmetic Dermatology

Volumn 11, Issue 4, 2012, Pages 279-289

  Raspaldo, Hervé ^a   Gassia, Véronique ^b   Niforos, François Rene ^c   Michaud, Thierry ^d  

^a Facial Plastic Surgery Centre   (France)

^b Private Practice   (France)

^c Private practice   (France)

^d Private Practice   (France)

Author keywords

Faceculpture ; Facial rejuvenation; Global approach; Periocular; Volume restoration

Indexed keywords

BOTULINUM TOXIN A; FILLER; HYALURONIC ACID;

AGING; ARTICLE; CONSENSUS; FACE; HUMAN; NASOJUGAL FOLD; NASOLABIAL FOLD; PERIOCULAR AREA REJUVINATION; PRIORITY JOURNAL; REJUVENATION; RISK BENEFIT ANALYSIS; WRINKLE;

BOTULINUM TOXINS, TYPE A; COSMETIC TECHNIQUES; DERMATOLOGIC AGENTS; EYEBROWS; EYELIDS; FOREHEAD; HUMANS; HYALURONIC ACID; NEUROMUSCULAR AGENTS; REJUVENATION; SKIN AGING;

EID: 84870021597     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/jocd.12003     Document Type: Article

References (33)

1. Carruthers JD, Glogau RG, Blitzer A. Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies - consensus recommendations. Plast Reconstr Surg 2008; 121(5 Suppl): 5S-30S.
2. Raspaldo H, Aziza R, Belhaouari L et al. How to achieve synergy between volumetry, filling products and botulinum toxin for global facial rejuvenation. J Cosmet Laser Ther 2011; 13: 77-86.
3. Brook RH. The RAND/UCLA appropriateness method. In: KAMS McCormick, RA Siegal, eds. Clinical Practice Guideline Development Methodology Perspectives. Rockville, Maryland: US Department of Health and Human Services; 1994: pp. 59-70.
4. Haute Autorité de Santé. Bases méthodologiques pour l'élaboration de recommandations professionnelles par consensus formalisé 2006: Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/base_methodo_CFE.pdf.
5. Lemperle G, Holmes RE, Cohen SR et al. A classification of facial wrinkles. Plast Reconstr Surg 2001; 108: 1735-50; discussion 51-52.
6. Carruthers A, Carruthers J, Hardas B et al. A validated brow positioning grading scale. Dermatol Surg 2008; 34(Suppl 2): S150-4.
7. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
8. de Maio M. The minimal approach: an innovation in facial cosmetic procedures. Aesth Plast Surg 2004; 28: 295-300.
9. Raspaldo H. Volumizing effect of a new hyaluronic acid sub-dermal facial filler: a retrospective analysis based on 102 cases. J Cosmet Laser Ther 2008; 10: 134-42.
10. Lambros V. Models of facial aging and implications for treatment. Clin Plast Surg 2008; 35: 319-27.
11. Hoffmann K (Juvéderm Voluma Study Investigators Group). Volumizing effects of a smooth, highly cohesive, viscous 20-mg/mL hyaluronic acid volumizing filler: prospective European study. BMC Dermatol 2009; 27: 1-9.
12. Fagien S, Raspaldo H. Facial rejuvenation with botulinum neurotoxin: an anatomical and experiential perspective. J Cosmet Laser Ther 2007; 9(suppl 1): 23-31.
13. Raspaldo H (ed.). New Era of Facial-3D Rejuvenation using Injectable Products and How to Measure the Results. Annual Conference in the 31st year of the European Academy of Facial Plastic Surgery; 2008 September 24-28; Düsseldorf: Medimond S.r.l.
14. Finn JC, Cox SE, Earl ML. Social implications of hyperfunctional facial lines. Dermatol Surg 2003; 29: 450-5.
15. Klein AW, Fagien S. Hyaluronic acid fillers and botulinum toxin type A: rationale for their individual and combined use for injectable facial rejuvenation. Plast Reconstr Surg 2007; 120(6 Suppl): 81S-8S.
16. Donath AS, Glasgold RA, Glasgold MJ. Volume loss versus gravity: new concepts in facial aging. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 238-43.
17. Wise JB, Greco T. Injectable treatments for the aging face. Facial Plast Surg 2006; 22: 140-6.
18. Rohrich RJ, Ghavami A, Crosby MA. The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations. Plast Reconstr Surg 2007; 120(6 Suppl): 41S-54S.
19. ™: a smooth, highly cohesive, volumizing hyaluronic acid gel for 3-dimensional facial rejuvenation. Prime 2011; 1: 16.
20. Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging 2008; 3: 153-9.
21. Fedok FG. Advances in minimally invasive facial rejuvenation. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 359-68.
22. Andre P. New trends in face rejuvenation by hyaluronic acid injections. J Cosmet Dermatol 2008; 7: 251-8.
23. ® approach. Dermatol Surg 2012; 38: 261-5.
24. Rohrich RJ. Advances in facial rejuvenation: Botulinum toxin A. Hyaluronic acid dermal fillers, and combination therapies-consensus recomendations. Editor's Foreword. Plast Reconstr Surg 2008; 121: 1S-2S.
25. Coleman KR, Carruthers J. Combination therapy with BOTOX and fillers: the new rejuvenation paradigm. Dermatol Ther 2006; 19: 177-88.
26. Matarasso SL, Carruthers JD, Jewell ML. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg 2006; 117: 3S-34S. discussion 35S-43S.
27. Raspaldo H, Baspeyras M, Bellity P et al. (Consensus Group) Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus - part 1. J Cosmet Dermatol 2011; 10: 36-50.
28. Liew S, Nguyen DQ. Nonsurgical volumetric upper periorbital rejuvenation: a plastic surgeon's perspective. Aesthet Plast Surg 2011; 35: 319-25.
29. Lambros V. Volumizing the brow with hyaluronic acid fillers. Aesthet Surg J 2009; 29: 174-9.
30. Fagien S. Temporary management of upper lid ptosis, lid malposition, and eyelid fissure asymmetry with botulinum toxin type A. Plast Reconstr Surg 2004; 114: 1892-902.
31. Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg 2006; 22: 335-41. discussion 341-343
32. Yaremchuk MJ, O'Sullivan N, Benslimane F. Reversing brow lifts. Aesthet Surg J 2007; 27: 367-75.
33. Rycroft-Malone J. Formal consensus: the development of a national clinical guideline. Qual Health Care 2001; 10: 238-44.